AGL icon

Agilon Health

1.38 USD
+0.05
3.76%
At close Aug 25, 4:00 PM EDT
After hours
1.38
+0.00
0.00%
1 day
3.76%
5 days
10.40%
1 month
-33.01%
3 months
-38.12%
6 months
-61.98%
Year to date
-28.13%
1 year
-68.49%
5 years
-95.55%
10 years
-95.55%
 

About: Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Employees: 1,076

0
Funds holding %
of 7,428 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

61% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 49

35% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 26

21% more call options, than puts

Call options by funds: $3.31M | Put options by funds: $2.73M

3% more funds holding

Funds holding: 197 [Q1] → 203 (+6) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

0.82% less ownership

Funds ownership: 97.17% [Q1] → 96.35% (-0.82%) [Q2]

49% less capital invested

Capital invested by funds: $1.79B [Q1] → $918M (-$876M) [Q2]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$1
28%
downside
Avg. target
$1.50
9%
upside
High target
$3
117%
upside

7 analyst ratings

positive
14%
neutral
71%
negative
14%
Bernstein
Lance Wilkes
1%upside
$1.40
Market Perform
Downgraded
20 Aug 2025
Jefferies
Jack Slevin
20%downside
$1.10
Hold
Maintained
15 Aug 2025
Baird
Michael Halloran
28%downside
$1
Neutral
Maintained
14 Aug 2025
Benchmark
Bill Sutherland
9%upside
$1.50
Buy
Maintained
6 Aug 2025
Barclays
Andrew Mok
9%upside
$1.50
Underweight
Maintained
6 Aug 2025

Financial journalist opinion

Based on 21 articles about AGL published over the past 30 days

Neutral
GlobeNewsWire
18 hours ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Neutral
PRNewsWire
3 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
NEW YORK , Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Neutral
GlobeNewsWire
4 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Negative
Zacks Investment Research
5 days ago
New Strong Sell Stocks for August 20th
AGL, CCRN and GOGL have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2025.
New Strong Sell Stocks for August 20th
Neutral
PRNewsWire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
NEW YORK , Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Neutral
PRNewsWire
2 weeks ago
agilon health, inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - AGL
LOS ANGELES , Aug. 12, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of agilon health, inc. ("Agilon" or "the Company") (NYSE: AGL) for violations of the securities laws.
agilon health, inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - AGL
Neutral
GlobeNewsWire
2 weeks ago
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Agilon Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options
AGILON ALERT: Bragar Eagel & Squire, P.C. is Investigating Agilon Health, Inc. on Behalf of Agilon Stockholders and Encourages Investors to Contact the Firm
Neutral
PRNewsWire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
NEW YORK , Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Neutral
GlobeNewsWire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Neutral
PRNewsWire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Charts implemented using Lightweight Charts™